Carbonylation of myosin heavy chains in rat heart during diabetes. - Wikidata - wikimedia - TriplyDB

Carbonylation of myosin heavy chains in rat heart during diabetes.

Carbonylation of myosin heavy chains in rat heart during diabetes.

http://www.wikidata.org/entity/Q34334665

about

Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy Gain of function of cardiac ryanodine receptor in a rat model of type 1 diabetes Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes Free fatty acid palmitate impairs the vitality and function of cultured human bladder smooth muscle cells.Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus.Cardiovascular redox and ox stress proteomics.N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy.Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies.Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells.A change of heart: oxidative stress in governing muscle function?Mitochondria in Structural and Functional Cardiac Remodeling.Sex, sex steroids, and diabetic cardiomyopathy: making the case for experimental focus.Reactivity, Selectivity, and Reaction Mechanisms of Aminoguanidine, Hydralazine, Pyridoxamine, and Carnosine as Sequestering Agents of Reactive Carbonyl Species: A Comparative Study.Carbonylation of atrial myosin prolongs its interaction with actin.Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases

P2860

Q27001165-675E5509-3935-4933-9971-6C8319748CC5 Q28389901-9E49F5D9-B26D-4B27-AAAE-56FE963A02AA Q28577628-C5B4A69B-8BFE-499F-BDE9-7B7EAE5FB170 Q34342527-437EE685-0BDE-4D63-9C33-7955AD76B04A Q36174773-370CDEB1-A61A-416A-A506-4B7487959475 Q36252927-F59D8193-D86D-4C0C-8C3B-F5E518C475C7 Q36339491-F3AC00CE-B91E-4D5B-AD71-19D1B733F959 Q36485424-8E1A52D8-3104-42E9-BF62-07B649078416 Q38151611-B925B25E-38C7-444C-ADA9-8D5BA5B5DFB1 Q38246367-83AC7E2B-6ABD-41B3-804C-3CDDB3C63FF7 Q38896058-CC814627-DA2F-4FBF-B163-F9A2F89AB559 Q39310989-B2F7669D-F388-4BCD-B9FE-EA42DE87C8D4 Q39334539-02B532E0-148C-4CBA-97E4-0CF3E48DC97E Q39398383-EF33D248-EDFB-493B-92B0-B134D4ED65AC Q46593878-94956A02-F76C-4554-9AE7-32147CE3739D Q51059078-71A57FC8-B53E-4A13-B46B-BEE0E59CF1DC Q58711702-57EAF9A3-8ED5-43BD-91B5-D73AF427C95F

P2860

Carbonylation of myosin heavy chains in rat heart during diabetes.

http://www.wikidata.org/entity/Q34334665

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Carbonylation of myosin heavy chains in rat heart during diabetes.

@ast

Carbonylation of myosin heavy chains in rat heart during diabetes.

@en

Carbonylation of myosin heavy chains in rat heart during diabetes.

@nl

type

label

Carbonylation of myosin heavy chains in rat heart during diabetes.

@ast

Carbonylation of myosin heavy chains in rat heart during diabetes.

@en

Carbonylation of myosin heavy chains in rat heart during diabetes.

@nl

prefLabel

Carbonylation of myosin heavy chains in rat heart during diabetes.

@ast

Carbonylation of myosin heavy chains in rat heart during diabetes.

@en

Carbonylation of myosin heavy chains in rat heart during diabetes.

@nl

P1433

Q34334665-FA92E786-6D03-4555-8FE2-559100D8D2CA

P1476

Q34334665-39068A6C-6D99-411D-B074-740A362D83F6

P2093

Q34334665-1C14AB81-F42A-4A77-83F6-7C373ADEAE54

Q34334665-2212DBCC-F558-438D-928F-648EA8BB396A

Q34334665-535AEAF9-55DF-408A-9F4E-5018003B1FA7

Q34334665-6EEA9BFA-9E1F-42B7-BDC8-FB59991602AB

Q34334665-781A7D4E-98B8-41BD-8D4E-2373F111D07D

Q34334665-7DA3CFCA-442C-452F-A3BC-D139136F42BE

Q34334665-9D82A7BD-B454-4853-A2A4-A6F0E6755214

Q34334665-CE7EB016-EAF1-4220-8F5F-7760125E698D

Q34334665-E0AB8DB2-B7A5-4A73-BAD2-C21069B88067

P2860

Q34334665-0F6C54BD-653F-471D-B79B-1C041E862D00

Q34334665-16774EEF-B50B-4961-AC27-831C5325881D

Q34334665-18EA0687-6ECA-4924-9D1D-5391152E2AE7

Q34334665-18EDB941-FFB1-4317-98EA-38001572BB30

Q34334665-2442AEC0-BACB-4694-A79F-3FE7495D6664

Q34334665-2F4F40DD-D6DF-4276-8FF8-41B47945B7E9

Q34334665-33538290-BE55-4A09-A6E1-405BA445F680

Q34334665-366058A2-4EF7-4240-A1B0-DF3771297D2A

Q34334665-39DA70C8-3759-42D5-A290-39E9C17C20B6

Q34334665-3B717B28-21FA-4ECA-BFE3-20FD3D6AE262

P304

Q34334665-AD3E27A7-A9FD-488E-BA13-A8DEAAB58084

P31

Q34334665-645B425B-38FD-4F1B-8BC0-AC120149377B

P356

Q34334665-495FAE85-BA86-4F28-9CE2-1F90195E368C

P407

Q34334665-AC3D9938-9F38-481D-B790-E16613150D64

P433

Q34334665-3C0E852D-9301-473F-995B-1422868E0F02

P478

Q34334665-93E4E5D7-01DD-4B2A-99C7-88A36A7E84E6

P577

Q34334665-F0CC8A11-A34C-4824-B0E7-5EB725BBC5DB

P5875

Q34334665-D55B3DA0-9B81-4487-99AE-37AA494B989E

P698

Q34334665-E0254C64-0CA9-4AC7-B9BF-626FD0D7F07F

P932

Q34334665-D3F2B80D-5D74-4F73-B79E-9FA8D017F938

P356

J.BCP.2010.03.024

P1433

Biochemical Pharmacology

P1476

Carbonylation of myosin heavy chains in rat heart during diabetes.

@en

P2093

Chun-Hong Shao

http://www.w3.org/2001/XMLSchema#string

Frank E Stockdale

http://www.w3.org/2001/XMLSchema#string

George J Rozanski

http://www.w3.org/2001/XMLSchema#string

Jaipaul Singh

http://www.w3.org/2001/XMLSchema#string

Kaushik P Patel

http://www.w3.org/2001/XMLSchema#string

Keshore R Bidasee

http://www.w3.org/2001/XMLSchema#string

Mu Wang

http://www.w3.org/2001/XMLSchema#string

Ryoji Nagai

http://www.w3.org/2001/XMLSchema#string

William G Mayhan

http://www.w3.org/2001/XMLSchema#string

P2860

Three conformational states of scallop myosin S1

Three-dimensional structure of myosin subfragment-1: a molecular motor

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Structure of the actin-myosin complex and its implications for muscle contraction

Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms

Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Effects of intensive glucose lowering in type 2 diabetes

An improved assay for nanomole amounts of inorganic phosphate

Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase.

P304

205-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BCP.2010.03.024

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42832694

http://www.w3.org/2001/XMLSchema#string

P698

20359464

http://www.w3.org/2001/XMLSchema#string

P932

2988575

http://www.w3.org/2001/XMLSchema#string